Eye Care Professionals

02/19/2026

Large cohort study links allergic rhinitis to higher risk of vision-threatening optic neuritis https://medicalxpress.com/news/2025-10-large-cohort-links-allergic-rhinitis.html

Sungkyunkwan University researchers in Korea ran a nationwide cohort analysis linking allergic diseases to increased optic neuritis risk, with allergic rhinitis showing the strongest association.

02/18/2026

Lesser-Known Signs of Retinoblastoma May Portend Advanced Disease

The presenting signs of retinoblastoma in children may include common ones such as leukocoria and strabismus and also less common ones such as unexplained orbital cellulitis.

02/17/2026

Week in Review: Delays in Ophthalmic Care for Prisoners, Diabetic Retinopathy Severity and Later Progression, Allergic Diseases and Optic Neuritis

Prisoners and detainees can suffer delays in ophthalmic care, worse diabetic retinopathy at diagnosis may predict future disease progression, patients with allergic diseases could be at risk for devel

02/16/2026

Aetna and Humana collaborate with AOA to exempt optometrists from auto- downcoding edits https://www.aoa.org//news/advocacy/third-party/aetna-and-humana-collaborate-with-aoa-to-exempt-optometrists-from-auto-downcoding-edits

02/15/2026

Semaglutide Use Does Not Appear to Affect the Risk of Many Eye Conditions, Except NAION

A systematic review evaluating semaglutide and the risk of various ocular disorders identified increased risk only of nonarteritic anterior ischemic optic neuropathy (NAION) with use of the drug.

02/14/2026

Weekly Journal Update — October 8, 2025

Vitelliform lesions in pachychoroid disease, risks for endophthalmitis after cataract surgery, OCT biomarkers and nAMD outcomes, sleep–wake disorders and glaucoma, 3-drug regimen for intraocular retin

02/13/2026

Extended 8 mg Aflibercept Protocols Demonstrate Sustained Control for nAMD

Long-term results of the phase 3 PULSAR study showed noninferiority of aflibercept 8 mg with extended 12- and 16-week dosing intervals for patients with neovascular AMD (nAMD).

02/12/2026

Live retinal imaging in mice reveals early immune cell activity before diabetes-related damage occurs https://medicalxpress.com/news/2025-10-retinal-imaging-mice-reveals-early.html

A new method of taking microscopic images of a live mouse's retina through the eye allows researchers to record the reaction of brain cells to disease and treatment. The Kobe University development is more easily applicable than previous methods and promises to advance research on and treatment of v...

02/11/2026

Children Bitten by Dogs Often Receive Periocular Injuries

Compared with adults, children who are bitten by dogs are more likely to be injured in the head, neck, and periocular areas.

02/10/2026

Week in Review: Using an “Eye-on-a-Chip” Model to Understand Corticosteroid-Induced Glaucoma, Links Between AMD and Atrial Fibrillation

Cornell University researchers create a model to study the molecular pathways behind corticosteroid-induced glaucoma, and patients with age-related macular degeneration (AMD) may be at increased risk

02/09/2026

Vision therapy reverses concussion-related double and blurred vision, study finds https://medicalxpress.com/news/2025-10-vision-therapy-reverses-concussion-blurred.html

Nearly half of adolescents and young adults with lingering symptoms of concussion suffer from eye coordination disorders that cause double and blurred vision, headaches and difficulties concentrating.

02/08/2026

AI Model Predicts Keratoconus Progression Risk From Just Two Visits

At the ESCRS Congress 2025, Dr. Shafi Balal introduced an artificial intelligence (AI) program that can stratify up to 90% of patients with keratoconus based on their 2-year risk of progression.